232 related articles for article (PubMed ID: 32773531)
21. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
Cimic A; Vranic S; Arguello D; Contreras E; Gatalica Z; Swensen J
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):299-304. PubMed ID: 33208671
[TBL] [Abstract][Full Text] [Related]
22. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Akhtar M; Al Hyassat S; Elaiwy O; Rashid S; Al-Nabet ADMH
Adv Anat Pathol; 2019 Nov; 26(6):421-427. PubMed ID: 31567131
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling of gastric neuroendocrine carcinomas.
Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and molecular characteristics of endometrial neuroendocrine carcinomas reveal preexisting endometrial carcinoma origin.
Ono K; Kasajima R; Katayama K; Miyagi Y; Yokose T
Pathol Int; 2021 Aug; 71(8):491-499. PubMed ID: 34015161
[TBL] [Abstract][Full Text] [Related]
25. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
26. NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?
Dinu A; Aschie M; Cozaru GC; Mitroi AF; Grasa CN; Iordache IE; Deacu M; Orasanu CI; Nicolau AA; Baltatescu GI
J Gastrointestin Liver Dis; 2023 Jun; 32(2):162-169. PubMed ID: 37345605
[TBL] [Abstract][Full Text] [Related]
27. Mixed Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm.
Maragliano R; Libera L; Carnevali I; Pensotti V; De Vecchi G; Testa M; Amaglio C; Leoni E; Formenti G; Sessa F; Furlan D; Uccella S
Endocr Pathol; 2022 Sep; 33(3):400-410. PubMed ID: 34342838
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
Hadoux J; Kanaan C; Durand A; Hescot S; Hautefeuille V; Cadiot G; Tauveron I; Laboureau S; Do Cao C; Walter T; Petorin C; Blanchet O; Jannin A; Gu C; Faron M; Leteurtre E; Rousselet MC; Zakeyh JJ; Marchal A; Chatelain D; Beaulaton C; Hervieu V; Ducreux M; Scoazec JY; Baudin E
Eur J Cancer; 2021 Jul; 152():100-115. PubMed ID: 34090142
[TBL] [Abstract][Full Text] [Related]
29. Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.
Vranic S; Palazzo J; Sanati S; Florento E; Contreras E; Xiu J; Swensen J; Gatalica Z
Clin Breast Cancer; 2019 Apr; 19(2):131-136. PubMed ID: 30268765
[TBL] [Abstract][Full Text] [Related]
30. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
31. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
Mulvany NJ; Allen DG
Int J Gynecol Pathol; 2008 Jan; 27(1):49-57. PubMed ID: 18156975
[TBL] [Abstract][Full Text] [Related]
32. Genetic alterations of GI-NECs involving three main signaling pathways.
Dai Q; Zhang J; Long W; Haybaeck J; Yang Z
Cancer Med; 2023 Apr; 12(7):8238-8250. PubMed ID: 36653904
[TBL] [Abstract][Full Text] [Related]
33. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
34. Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract][Full Text] [Related]
35. Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.
Sciarra A; Missiaglia E; Trimech M; Melloul E; Brouland JP; Sempoux C; La Rosa S
Endocr Pathol; 2020 Mar; 31(1):84-93. PubMed ID: 31981075
[TBL] [Abstract][Full Text] [Related]
36. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
37. In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
Hermans BCM; Derks JL; Hillen LM; van der Baan I; van den Broek EC; von der Thüsen JH; van Suylen RJ; Atmodimedjo PN; den Toom TD; Coumans-Stallinga C; Timens W; Dinjens WNM; Dubbink HJ; Speel EM; Dingemans AC;
Int J Cancer; 2022 Mar; 150(5):802-815. PubMed ID: 34674268
[TBL] [Abstract][Full Text] [Related]
38. Targeted mutation analysis of endometrial clear cell carcinoma.
Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.
Pocrnich CE; Ramalingam P; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):577-86. PubMed ID: 26945341
[TBL] [Abstract][Full Text] [Related]
40. Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.
Iijima M; Yokobori T; Mogi A; Shimizu K; Yajima T; Kosaka T; Ohtaki Y; Obayashi K; Nakazawa S; Gombodorj N; Tsukagoshi M; Shirabe K; Kuwano H
Ann Surg Oncol; 2019 Jun; 26(6):1744-1750. PubMed ID: 30924018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
